Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027

U.S. News & World Report has recognized Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as the #1 pediatric cancer program in the nation in its 2026-2027 Best Children’s Hospitals report.

  • By

  • September 15, 2026

  • 3 min

Share

Objective:

To announce the recognition of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as the top pediatric cancer program in the U.S. for 2026-2027.

Approach:
  • Ranking Methodology: U.S. News & World Report, in collaboration with RTI International, analyzed data from 114 children’s hospitals and surveyed thousands of pediatric specialists to determine rankings based on clinical outcomes, compliance with established best practices, and level and quality of hospital resources directly related to patient care.
Key Findings:
  • Dana-Farber/Boston Children’s has been ranked among the top three pediatric cancer centers since 2007.
  • The center has received more #1 rankings than any other program.
  • The recognition reflects a commitment to personalized cancer care and innovative therapies.
Interpretation:

The ranking signifies the center's excellence in pediatric cancer care, driven by collaborative expertise and resources from two leading institutions.

Conclusion:

The recognition highlights the center's dedication to providing high-quality care and advancing research in pediatric hematology/oncology.

Sources:

Original Source(s)

Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027

  • by

  • September 15, 2026

Related Content

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

  • September 16, 2026

  • 2 min
CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Comment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines